GAS5

ncRNA information

ncRNA name

GAS5

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

miRNA-21

Cancer information

Cancer name

Cervical Cancer

Cancer site

Cervix Uteri

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

We found that high expression of GAS5 and low expression of miR-21 can enhance the sensitivity of SiHa/cDDP cancer cells to cisplatin.

Tissue resource

cervical cancer and normal cervical tissue specimens

cervical cancer cell lines HeLa

cervical cancer cell lines SiHa

cervical cancer cell lines CaSki

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

the Third Affiliated Hospital of Guangzhou Medical University

American Type Culture Collection

Country

China

USA

Continent

Asia

Amercia